An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Mise à jour : Il y a 4 ans
Référence : NCT00501969

Femme et Homme

Extrait

The objective of this open-label extension is to assess the safety and tolerability of long-term treatment of the rotigotine patch in subjects with advanced-stage idiopathic Parkinson's disease


Critère d'inclusion

  • Advanced Stage Parkinson's Disease


Liens